Skip to content
PharmaManufacturingIQ

GenAI and drug discovery: the best is yet to come

Adrian Tombling, partner and patent attorney, Withers & Rogers explores the future of GenAI and drug discovery.

By PharmaManufacturing IQ Staff
GenAI and drug discovery: the best is yet to come
Published: | 4 min read
Share to X Share to Bluesky Share to Facebook Share to LinkedIn Share by email

Adrian Tombling, partner and patent attorney, Withers & Rogers explores the future of GenAI and drug discovery.

Withers & Rogers

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information